Last update:
Weight management news
WHO says no obesity drugs, surgery for under-10s
Medicine and surgery are not the answer for overweight children, the World Health Organization said Thursday.
7 hours ago
0
3
Dying fat cells may trigger self-amplifying cycle of inflammation in obesity
A new review examines adipocyte ferroptosis, the breakdown of fat cells due to oxidation from intracellular iron, as an emerging molecular mechanism potentially contributing to adipose tissue dysfunction, chronic inflammation ...
4 hours ago
0
0
Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment
Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference and other factors—and often ...
11 hours ago
0
3
Exercise as medicine: How physical activity helps manage chronic disease
Chronic diseases such as diabetes, heart disease, high blood pressure, arthritis and certain types of cancer are leading causes of disability and death worldwide. Traditionally, these conditions have been managed through ...
22 hours ago
0
6
Childhood obesity less common under new health-based definition
A new global definition of clinical obesity classifies far fewer children as obese than widely used body mass index (BMI) thresholds, according to a large international study. The findings could lead to changes in how childhood ...
Oct 6, 2026
0
28
Obesity's link to lower risk of death in dementia points to likely importance of nutrition
People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU ...
Oct 6, 2026
0
29
Popular diabetes drug shown to lower inflammation, which may protect the heart
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown to reduce inflammatory ...
Oct 6, 2026
0
12
Inflammation may push people with obesity toward easier, often less healthy food choices
Around half of people who are severely overweight have mild inflammation in their bodies. Research by neuroscientist Judith Scholing of the Donders Institute at Radboud University shows that this inflammation can cause people ...
Oct 5, 2026
0
39
Warm temperatures curb appetite but can still promote weight gain, animal experiments find
Researchers at Pennington Biomedical Research Center have identified a key brain mechanism that connects environmental temperature with appetite and energy balance, offering new insight into how external conditions can shape ...
Oct 5, 2026
0
13
No detectable increase in pregnancy risks after GLP-1 exposure around conception, largest review to date finds
Exposure to GLP-1 weight-loss and diabetes drugs around conception is not linked to a clearly detectable increase in adverse outcomes for mothers or babies, according to the largest study of its kind, involving more than ...
Oct 5, 2026
0
11
Health records from 68 adults link plant-based grocery support to lower blood pressure and weight
Providing people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension. However, most studies of "Food Is Medicine" programs have only looked at their short-term ...
Oct 4, 2026
0
150
New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells
Details of a new injection that targets fat cells will be released at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2). Studies show that the new drug, CBL-514, ...
Oct 2, 2026
0
2939
Low-calorie diet and exercise put early-onset type 2 diabetes in remission for 54% of participants
New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and appearing in The Lancet Regional Health Americas journal shows that in people ...
Oct 2, 2026
0
386
A molecular switch syncs fat burning to the body clock, our diet and the temperature around us
Brown fat burns fuel to make heat, and this activity is controlled by the body clock: It drops during sleep and rises before waking. But a cold morning or a skipped meal makes demands the clock never planned for. How the ...
Oct 1, 2026
0
22
New triple agonist drug produces substantial weight loss in diabetic patients
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and appearing in The Lancet shows that treatment with the new triple agonist ...
Oct 1, 2026
0
103
GLP-1 prescriptions for new mothers have increased sharply
More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
Oct 1, 2026
0
18
Clinical trial provides preliminary evidence of blood-pressure effect from feijoa
The world's first clinical trial of feijoa has provided preliminary evidence that the fruit reduces blood pressure during weight loss. The unexpected finding was incidental to studying feijoa's potential for preventing type ...
Oct 1, 2026
0
73
Experimental obesity drug targets appetite through amylin, offering potential alternative to GLP-1 therapies
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Diabetes & Endocrinology shows that weekly injections ...
Sep 30, 2026
0
83
Focusing on the 'obesity paradox' to improve cancer treatment success
In research published in the journal Nature, McGill University researchers looked at the relationship between diet, the gut microbiome and patient response to immune checkpoint blockade. To their surprise, certain diets often ...
Sep 30, 2026
0
23
Trevogrumab (anti-myostatin) can help preserve lean mass during and after semaglutide-induced weight loss
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, and in press at The Lancet shows that trevogrumab, which inhibits a protein that ...
Sep 30, 2026
0
186
Daily pill could offer alternative to insulin injections for diabetes patients at cardiovascular risk
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, and published in The Lancet shows that, for people with type 2 diabetes at increased ...
Sep 30, 2026
0
26
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
New research to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Obstetrics, Gynaecology & Women's Health shows ...
Sep 30, 2026
0
20
Higher GLP-1 costs lead to lower adherence
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
8
New investigational drug delivers up to 23.3% weight loss in people with obesity and diabetes
New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), show that, for people living with obesity and type ...
Sep 30, 2026
0
119
Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health ...
Sep 30, 2026
0
7
